US Broker Ratings

Immunocore Holdings plc (IMCR) Stock Analysis: Is a 98% Upside Potential Just Around the Corner?

Immunocore Holdings plc (NASDAQ: IMCR), a pioneering name in the biotechnology sector, has captured the attention of investors with its innovative approach to immunotherapy. Based in..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Unveiling a Potential 176% Upside in the Biotechnology Sector

For investors interested in the Healthcare sector’s promising biotechnology niche, Amicus Therapeutics, Inc. (NASDAQ: FOLD) presents a captivating opportunity. With a focus on rare diseases, the..

Twist Bioscience Corporation (TWST) Stock Analysis: Unveiling a 31.6% Upside Potential in the Healthcare Sector

Twist Bioscience Corporation (NASDAQ: TWST), a prominent player in the healthcare sector, is making waves in the diagnostics and research industry. Headquartered in South San Francisco,..

Clover Health Investments, Corp (CLOV): Investor Outlook with a 68% Potential Upside

Clover Health Investments, Corp (NASDAQ: CLOV), a player in the healthcare plans sector, is drawing significant attention from investors, thanks to its impressive growth prospects and..

PTC Therapeutics, Inc. (PTCT) Investor Outlook: Exploring a Potential 28.61% Upside in the Biotechnology Sector

PTC Therapeutics, Inc. (NASDAQ: PTCT) stands out in the biotechnology sector with a compelling narrative for investors seeking exposure to the healthcare industry. With a market..

Amneal Pharmaceuticals, Inc. (AMRX) Investor Outlook: A 45% Upside Potential Catches Attention

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX), with its diverse portfolio of generic and specialty pharmaceutical products, presents an intriguing opportunity for investors, particularly given its potential upside..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 36.6% Upside Potential

For investors seeking exposure in the healthcare sector, Perrigo Company plc (NYSE: PRGO) presents a compelling opportunity with a projected upside of 36.6%. This Irish-based company..

Enovis Corporation (ENOV) Stock Analysis: Exploring an 80% Upside Potential in the Medical Device Sector

Enovis Corporation (NYSE: ENOV) is gaining attention in the investment community, primarily due to its substantial upside potential. As a healthcare-focused entity within the medical devices..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Biotech Gem with 34.8% Upside Potential

Mirum Pharmaceuticals, Inc. (MIRM), a promising player in the biotechnology sector, is capturing investor attention with its significant growth potential and innovative approach to treating rare..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: Unraveling a 37% Potential Upside

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) has captured the attention of investors with its promising pipeline and substantial growth potential in the biopharmaceutical sector. Based in London,..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring a Potential 55% Upside in the Biotech Sector

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is capturing the attention of investors with its promising prospects in the biotechnology sector. With a market capitalization of $1.93 billion,..

CG Oncology, Inc. (CGON) Stock Analysis: Exploring a 132% Potential Upside in the Biotechnology Sector

Investors are often on the lookout for compelling opportunities in the healthcare sector, and CG Oncology, Inc. (NASDAQ: CGON) presents an intriguing case. As a biotechnology..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a 19.32% Potential Upside in the Growing Fertility Benefits Sector

Progyny, Inc. (NASDAQ: PGNY) stands at the intersection of healthcare innovation and employee benefits, offering a unique value proposition within the fertility and family-building sector. As..

PROCEPT BioRobotics (PRCT) Stock Analysis: A 33% Upside Potential in the Medical Device Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a rising star in the healthcare sector, operates at the intersection of medical devices and robotics. With a market capitalization of..

Certara, Inc. (CERT) Stock Analysis: Exploring a 34.85% Potential Upside

Certara, Inc. (NASDAQ: CERT) stands at the forefront of the healthcare sector, specializing in health information services. With a market capitalization of $1.9 billion, Certara provides..

Vericel Corporation (VCEL): Analyst Consensus Favors ‘Buy’ with 39.54% Potential Upside

Vericel Corporation (NASDAQ: VCEL), a prominent player in the biopharmaceutical sector, has captured the attention of investors with its notable growth potential and strong analyst consensus...

Recursion Pharmaceuticals (RXRX) Stock Analysis: Navigating the 41.16% Potential Upside Amidst a Biotech Revolution

Recursion Pharmaceuticals, Inc. (RXRX), a pioneering force in the biotechnology sector, is capturing investor attention with its robust pipeline of drug discovery and a potential upside..

Belite Bio, Inc (BLTE) Stock Analysis: A 47% Upside Potential for This Biotech Innovator

For individual investors with an eye on the healthcare sector, Belite Bio, Inc (NASDAQ: BLTE) presents an intriguing opportunity in the biotechnology industry. With a robust..

Kymera Therapeutics (KYMR) Stock Analysis: A Healthcare Innovator with Nearly 40% Upside Potential

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is a compelling player in the biotechnology sector, commanding attention with its innovative approach to drug development and promising growth prospects...

Viking Therapeutics, Inc. (VKTX) Investor Outlook: Assessing a 240% Upside Potential

Viking Therapeutics, Inc. (NASDAQ: VKTX) stands out in the biotechnology sector with a remarkable potential upside of 240.62% according to analyst ratings. This company, headquartered in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds